Cardiometabolic Effectiveness and Safety of SGLT2 Inhibitors in Patients with Type 2 Diabetes Mellitus at High Cardiovascular Risk: A Prospective Observational Study
Background: Type 2 diabetes mellitus (T2DM) is associated with substantial cardiovascular and renal morbidity. Sodium-glucose cotransporter-2 (SGLT2) inhibitors have emerged as an important therapeutic class because their effects extend beyond glycemic control to include reductions in body weight, blood pressure, cardi...